Skip to content
10-Q

Quarterly Report

Damora Therapeutics, Inc. DMRA

0001193125-25-269426

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 1.33M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.33M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.32M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.14M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.1M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$7.29M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$13.69M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $7.61M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $14.18M
Stockholders Equity Q3 2025 · Sep 30, 2025 $8.01M
Stockholders Equity Q3 2025 · Jun 30, 2025 $10.95M
Stockholders Equity Q3 2025 · Dec 31, 2024 $15.83M
Stockholders Equity Q3 2025 · Sep 30, 2024 $20.94M
Stockholders Equity Q3 2025 · Jun 30, 2024 $23.59M
Stockholders Equity Q3 2025 · Dec 31, 2023 $32.33M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.62M
Current Liabilities Q3 2025 · Dec 31, 2024 $1.2M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.73M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.3M
Current Assets Q3 2025 · Sep 30, 2025 $9.79M
Current Assets Q3 2025 · Dec 31, 2024 $16.84M
Total Assets Q3 2025 · Sep 30, 2025 $10.74M
Total Assets Q3 2025 · Dec 31, 2024 $17.13M
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.36
Eps Diluted Q3 2025 · Sep 30, 2025 −$6.88
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.39
Eps Diluted Q3 2025 · Sep 30, 2024 −$13.30
Eps Basic Q3 2025 · Sep 30, 2025 −$2.36
Eps Basic Q3 2025 · Sep 30, 2025 −$6.88
Eps Basic Q3 2025 · Sep 30, 2024 −$3.39
Eps Basic Q3 2025 · Sep 30, 2024 −$13.30
Sga Expense Q3 2025 · Sep 30, 2025 $1.74M
Sga Expense Q3 2025 · Sep 30, 2025 $5.62M
Sga Expense Q3 2025 · Sep 30, 2024 $2.75M
Sga Expense Q3 2025 · Sep 30, 2024 $8.8M
Rd Expense Q3 2025 · Sep 30, 2025 $1.42M
Rd Expense Q3 2025 · Sep 30, 2025 $3.56M
Rd Expense Q3 2025 · Sep 30, 2024 $1.09M
Rd Expense Q3 2025 · Sep 30, 2024 $5.39M
Net Income Q3 2025 · Sep 30, 2025 −$3.13M
Net Income Q3 2025 · Sep 30, 2025 −$9.1M
Net Income Q3 2025 · Sep 30, 2024 −$3.88M
Net Income Q3 2025 · Sep 30, 2024 −$14.7M
Operating Income Q3 2025 · Sep 30, 2025 −$3.16M
Operating Income Q3 2025 · Sep 30, 2025 −$9.18M
Operating Income Q3 2025 · Sep 30, 2024 −$3.84M
Operating Income Q3 2025 · Sep 30, 2024 −$15.16M